1. Kim B, Myung R, Kim J, Lee MJ, Pai H. Descriptive epidemiology of acute pyelonephritis in Korea, 2010–2014: population-based study. J Korean Med Sci 2018;33:e310.

2. Czajkowski K, Broś-Konopielko M, Teliga-Czajkowska J. Urinary tract infection in women. Prz Menopauzalny 2021;20:40–47.

3. Berg E, Benson DM, Haraszkiewicz P, Grieb J, McDonald J. High prevalence of sexually transmitted diseases in women with urinary infections. Acad Emerg Med 1996;3:1030–1034.

4. Moore EE, Hawes SE, Scholes D, Boyko EJ, Hughes JP, Fihn SD. Sexual intercourse and risk of symptomatic urinary tract infection in post-menopausal women. J Gen Intern Med 2008;23:595–599.

5. Tomas ME, Getman D, Donskey CJ, Hecker MT. Overdiagnosis of urinary tract infection and underdiagnosis of sexually transmitted infection in adult women presenting to an emergency department. J Clin Microbiol 2015;53:2686–2692.

6. Shapiro T, Dalton M, Hammock J, Lavery R, Matjucha J, Salo DF. The prevalence of urinary tract infections and sexually transmitted disease in women with symptoms of a simple urinary tract infection stratified by low colony count criteria. Acad Emerg Med 2005;12:38–44.

7. Behzadi P, Behzadi E, Pawlak-Adamska EA. Urinary tract infections (UTIs) or genital tract infections (GTIs)? It’s the diagnostics that count. GMS Hyg Infect Control 2019;14:Doc14.

8. Kreisel KM, Spicknall IH, Gargano JW, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018. Sex Transm Dis 2021;48:208–214.

9. Weinstock HS, Kreisel KM, Spicknall IH, Chesson HW, Miller WC. STI prevalence, incidence, and costs in the United States: new estimates, new approach. Sex Transm Dis 2021;48:207.

10. Hillier SL, Bernstein KT, Aral S. A review of the challenges and complexities in the diagnosis, etiology, epidemiology, and pathogenesis of pelvic inflammatory disease. J Infect Dis 2021;224(12 Suppl 2):S23–S28.

11. Mitchell CM, Anyalechi GE, Cohen CR, Haggerty CL, Manhart LE, Hillier SL. Etiology and diagnosis of pelvic inflammatory disease: looking beyond gonorrhea and chlamydia. J Infect Dis 2021;224(12 Suppl 2):S29–S35.

12. Mitchell C, Prabhu M. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am 2013;27:793–809.

13. Wie SH, Ki M, Kim J, et al. Clinical characteristics predicting early clinical failure after 72 h of antibiotic treatment in women with community-onset acute pyelonephritis: a prospective multicentre study. Clin Microbiol Infect 2014;20:O721–O729.

14. Park JH, Wee JH, Choi SP, Park KN. Serum procalcitonin level for the prediction of severity in women with acute pyelonephritis in the ED: value of procalcitonin in acute pyelonephritis. Am J Emerg Med 2013;31:1092–1097.

15. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021;70:1–187.

16. Huppert JS, Biro F, Lan D, Mortensen JE, Reed J, Slap GB. Urinary symptoms in adolescent females: STI or UTI? J Adolesc Health 2007;40:418–424.

17. Yudin MH, Hillier SL, Wiesenfeld HC, Krohn MA, Amortegui AA, Sweet RL. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 2003;188:318–323.

18. Komesu YM, Dinwiddie DL, Richter HE, et al. Defining the relationship between vaginal and urinary microbiomes. Am J Obstet Gynecol 2020;222:154e1–154.e10.

19. Sprong KE, Mabenge M, Wright CA, Govender S. Ureaplasma species and preterm birth: current perspectives. Crit Rev Microbiol 2020;46:169–181.

20. Zhu CT, Hu ZY, Dong CL, Zhang CS, Wan MZ, Ling Y. Investigation of Ureaplasma urealyticum biovars and their relationship with antimicrobial resistance. Indian J Med Microbiol 2011;29:288–292.

21. Kokkayil P, Dhawan B. Ureaplasma: current perspectives. Indian J Med Microbiol 2015;33:205–214.

22. Rumyantseva T, Khayrullina G, Guschin A, Donders G. Prevalence of Ureaplasma spp. and Mycoplasma hominis in healthy women and patients with flora alterations. Diagn Microbiol Infect Dis 2019;93:227–231.

23. Kletzel HH, Rotem R, Barg M, Michaeli J, Reichman O. Ureaplasma urealyticum: the role as a pathogen in women’s health, a systematic review. Curr Infect Dis Rep 2018;20:33.

24. Lee GH, Kim HJ, Park CH, et al. Frequency of N. gonorrheaee, C. trachomatis, U. urealyticum and M. hominis in pelvic inflammatory disease and Fitz-Hugh-Curtis syndrome. Infect Chemother 2012;44:362–366. 25. Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ 2019;97:548–562.